CSI Market
Sign In | Register

Alnylam Pharmaceuticals Inc (ALNY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ALNY Annual Balance Sheets →
Examining balance sheet movements between Alnylam Pharmaceuticals Inc and Sep 30 2025 reveals how Sep 30 2026 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent1,754.34
Available-for-sale Securities, Debt Securities, Current MA1,832.92
Cash & Short-term Investments3,586.00
Accounts receivable1,084.91
Inventories105.91
Other Current Assets0.00
Prepaid Expense And Other Assets Current334.60
Total Current Assets5,112.66
Equipment/Property/Plant Net614.91
Long-term investments22.17
Other Assets, Noncurrent2,244.93
Equity Securities Fv Ni-
Operating Lease Right Of Use Asset189.30
Total Assets7,994.67
Liabilities
Accounts Payable, Current AC135.40
Accrued Liabilities, Current AC1,236.29
Derivative Liability, Current DE0.00
Short-term Debt361.53
Other Liabilities, Current329.79
Total Current Liabilities2,063.01
Convertible Debt, Noncurrent LO651.09
Total Long-term Debt651.09
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent1,676.73
Operating Lease Liability Current45.66
Operating Lease Liability Noncurrent218.03
Total Liabilities4,390.82
Stockholders' Equity
Common Stock Value1.34
Additional Paid In Capital Common Stock7,811.88
Retained Earnings / Accumulated Deficit-4,164.70
Accumulated Other Comprehensive Income-44.66
Other Equity-44.66
Common Stockholder's Equity3,603.85
Total Stockholder's Equity3,603.85
Liabilities & Stockholder's Equity7,994.67
4 historic quarters locked

Sign in to unlock the full Alnylam Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Alnylam Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001178670-26-000076

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI